IRIS
MARINELLI BUSILACCHI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 650
EU - Europa 342
AS - Asia 39
Totale 1.031
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 650
IT - Italia 163
IE - Irlanda 42
SE - Svezia 41
UA - Ucraina 26
DE - Germania 17
GB - Regno Unito 15
SG - Singapore 14
RO - Romania 12
CN - Cina 8
DK - Danimarca 7
FR - Francia 7
FI - Finlandia 5
IN - India 4
KR - Corea 4
NL - Olanda 4
TR - Turchia 3
CH - Svizzera 2
IR - Iran 2
TH - Thailandia 2
BE - Belgio 1
JP - Giappone 1
VN - Vietnam 1
Totale 1.031
Salva come PNG Salva come JPEG
Città #
Chandler 84
Fairfield 69
Des Moines 52
New York 44
Dublin 42
Ashburn 41
Jacksonville 36
Woodbridge 33
Redmond 30
Wilmington 28
Seattle 27
Houston 24
Centro 16
Marche 16
Turin 15
Boardman 14
Cambridge 13
Brasov 12
Lawrence 12
Princeton 12
Rome 11
San Benedetto del Tronto 10
San Mateo 10
Ann Arbor 7
Iesi 7
San Diego 7
Cagliari 6
London 5
Beijing 4
Bristol 4
Los Angeles 4
Milan 4
Pune 4
Ancona 3
Bologna 3
Tolentino 3
Washington 3
Bangkok 2
Campobasso 2
Chiaravalle 2
Falconara Marittima 2
Helsinki 2
Kilburn 2
Marsciano 2
Pesaro 2
Varese 2
Zurich 2
Acerra 1
Acquaviva Picena 1
Brussels 1
Campogalliano 1
Cantu 1
Cedar Knolls 1
Chicago 1
Chieti 1
Dong Ket 1
Fayetteville 1
Guangzhou 1
Hounslow 1
Kish 1
Macerata 1
Monsampolo del Tronto 1
Montemarciano 1
Morrovalle 1
Nanjing 1
New Bedfont 1
Parrano 1
Pescara 1
Porto 1
Redwood City 1
Ripa Teatina 1
Sant'Anastasia 1
Secaucus 1
Seregno 1
Tappahannock 1
The Dalles 1
Wuhan 1
Totale 765
Salva come PNG Salva come JPEG
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 145
Pre-eclampsia onset and SPARC: A possible involvement in placenta development. 131
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 96
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 88
Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells 81
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 79
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 78
Basi cellulari e molecolari della Graft-Versus-Host Desease 78
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 72
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 51
null 42
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 36
Modulation of matrix metalloproteases by ciliary neurotrophic factor in human placental development 31
Novel Translational Read-Through–Inducing Drugs as A Therapeutic Option for Shwachman-Diamond Syndrome 25
A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure 22
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 17
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 7
Specific Anti-Nuclear Antibodies, Clinical Features and Outcome Following Treatment with Nilotinib In Patients with Chronic Graft-Versus-Host Disease. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions 2
Totale 1.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/202065 4 0 5 2 7 0 5 5 6 2 10 19
2020/2021303 14 15 17 10 29 59 39 18 21 30 21 30
2021/2022107 0 12 5 1 1 8 11 6 9 15 9 30
2022/2023339 24 38 17 22 14 88 1 16 71 1 41 6
2023/2024201 23 2 12 26 32 63 12 18 4 9 0 0
Totale 1.081